EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Quantum Dot: The Future of Personalized Medicine
Cancer is amongst the most significant health hazards around the globe Individualized chemotherapy offers promise for the forthcoming cancer therapy in clinical practice with each patient receiving tailored medication based on essential biological aspects of a specific tumor One of the most pressing issues is the development of innovative ways for personalized
Circular Logistics: A Strategic Advantage for U.S. Pharmaceutical Supply Chains in an Era of Uncertainty
Temperaturerelated failures are estimated to cost the industry billion annually highlighting a nonnegotiable requirement for reliability product integrity and regulatory compliance For manufacturers
Regulatory Challenges in Clinical Testing for New Pharmaceuticals
The clinical testing is a stage where the new pharmaceutical products are a trial on human beings or patients The aims of clinical trials are to assess the effectivenesssafetytolerability or intolerance of new drug in man Generally clinical trials are conducted in phases each phase has different questions regarding the drug
Why is Pharmacogenetics and Pharmacogenomics Important?
In a world of increasingly personalized medicine the fields of pharmacogenetics and pharmacogenomics are gaining importance These disciplines explore the relationship between an individuals genetic makeup
The Architect of the Void: When 3D Printing Becomes the Body’s New Bone
In the quiet pressurised hum of a modern surgical suite a surgeon holds a highdefinition scan of a young patients femur On the screen a jagged dark shadow marks where an osteosarcoma has claimed its territory For decades the script for this moment has been written in cold hard steel
Robotic Process Automation: The Catalyst for Pharma 4.0 Evolution
The pharmaceutical industry is experiencing a massive shift to new era phase known as Industry or less commonly known as Pharma in this context In the middle of this transformational journey we have Robotic Process Automation RPA as a tool that is disruptive in the way these pharmaceutical organizations are run and managed
-
Techno Trends
University of Queensland Researchers Unlock New Drug Target for Neurodegenerative Disease Therapies
University of Queensland UQ researchers have developed a novel drug molecule that targets the hardtostudy immune receptor CaR opening new possibilities for treatments targeting neurodegenerative diseases such as Motor Neurone Disease MND
-
Projects
Evonik Announces US$100 Million Modernization of U.S. Drug Substance CDMO Facility
Evonik has announced a US million investment to modernize its Tippecanoe Labs manufacturing site in Lafayette Indiana over the next five years The investment is aimed at strengthening the companys US drug substance
-
Research Insights
A genomic-led strategy to anticipate drug safety effects
Safetyrelated issues account for approximately of failures in new drug discovery programs On top of that many are discovered during postmarketing surveillance
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Circular Logistics: A Strategic Advantage for U.S. Pharmaceutical Supply Chains in an Era of Uncertainty
Barbara Morgan
Pharmaceutical supply chains in the United States are under sustained pressure. Rising costs, inflation, shifting trade dynamics and ongoing global disruption are forcing companies to rethink how logi...
-
2
Regulatory Challenges in Clinical Testing for New Pharmaceuticals
Kate Williamson
The development of new drugs is quite a protracted process, which goes through some stages, ensuring that therapeutic products would not be toxic to patients and would adequately provide agreed-upon t...
-
3
Why is Pharmacogenetics and Pharmacogenomics Important?
Kate Williamson
Pharmacogenetics and pharmacogenomics, exploring genetic influences on drug response, are pivotal in personalized medicine. By tailoring treatments to individual genetic makeup, these fields enhance d...
-
4
The Architect of the Void: When 3D Printing Becomes the Body’s New Bone
Baher A. Daihom
This article explores the transformative role of 3D bioprinting in treating bone cancer. By integrating patient-specific scaffolds with localised, time-released chemotherapy and osteoinductive bio-ink...
-
5
Robotic Process Automation: The Catalyst for Pharma 4.0 Evolution
Kate Williamson
Robotic Process Automation (RPA) is essential in the Pharma 4.0 evolution, varying the pharmaceutical industry by automating repetitive tasks, reducing human errors, and enhancing efficiency. RPA supp...
press releases Read more...
FairJourney Bio Delivers Antibody Engineering for Novel Tumor-Conditional IL-12 Therapeutic Approach That Unlocks the Potential of Localized Cytokine Activation
FairJourney Bio FJBio a global antibody discovery expert today announced the publication of a peerreviewed study in mAbs describing a novel approach with the potential to improve the therapeutic window of IL
Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline
Ipsen announced today it has completed the acquisition of Kartos Therapeutics a clinicalstage biopharmaceutical company adding latestage MDM inhibitor navtemadlin in Phase III clinical development in myelofibrosis
Galen and POA Pharma unveil Galsana, a new global brand for rare metabolic diseases
At the SSIEM Annual Symposium in Helsinki Galen Ltd and POA Pharma announced the launch of Galsana a new global brand for their metabolic product portfolio bringing together established products
Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026
Infex Therapeutics a leading antiinfectives specialist today announced that new Phase IIa study data for RESPX INFEX its firstinclass antivirulence monoclonal antibody therapy in development for NCFB patients
Events Read more...
19 - 21
Aug 2026ISPE Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
03 - 05
Sep 20265th MENA Congress for Rare Diseases 2026
Beach Rotana Hotel, Abu Dhabi,...
14 - 16
Sep 2026LATEST NEWS Read more...
Lupin and Tenpoint Therapeutics partner to commercialise YUVEZZI™ across European markets
Lupin Limited has announced that its wholly owned subsidiary VISUfarma BV has entered into an exclusive licensing agreement with Visus Therapeutics Inc a wholly owned subsidiary of Tenpoint Therapeutics Holding Limited
Rein Therapeutics receives US FDA Fast Track designation for LTI-03 in idiopathic pulmonary fibrosis
Rein Therapeutics has received Fast Track designation from the US Food and Drug Administration FDA for LTI an investigational treatment being developed for idiopathic pulmonary fibrosis IPF
IDEAYA Biosciences Announces Clinical Collaboration with Genentech for MTAP-Deleted, KRAS G12D-Mutant Pancreatic Cancer
IDEAYA Biosciences Inc NASDAQ IDYA has entered into a clinical collaboration with Genentech a member of the Roche Group to evaluate IDE in combination with GDC RG in patients
NTx Bio Supports Baylor College of Medicine in Manufacturing Personalised Cancer Vaccine for Phase 1 Melanoma Trial
NTx Bio is supporting Baylor College of Medicine in the manufacturing of a personalised cancer vaccine being evaluated in Diakonos Oncologys Phase trial for patients with refractory melanoma
VectorBuilder and Lir Therapeutics partner to advance AAV capsids for clinical development
VectorBuilder and Lir Therapeutics have entered into a strategic collaboration to develop adenoassociated virus AAV capsids that combine strong biological performance with the manufacturing and scalability requirements needed for clinical development
Cytovance Biologics launches standalone analytical services for biologics development
Cytovance Biologics has expanded its analytical services portfolio to provide standalone analytical support for biotechnology and pharmaceutical companies The new offering gives clients access to Cytovances analytical expertise and regulatoryready solutions without requiring a manufacturing engageme...









